Identification
- Summary
Ginger is an extract from Ginger used in allergy testing.
- Generic Name
- Ginger
- DrugBank Accession Number
- DB10344
- Background
Ginger allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Ginger Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US 
Ginger Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Ginger Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Ginger Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US Ginger Injection, solution 1 g/20mL Percutaneous; Subcutaneous Allergy Laboratories, Inc. 1972-08-29 Not applicable US Ginger Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Ginger Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Ginger Capsule 710 mg / cap Oral Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. 2000-01-21 2002-07-29 Canada 
Ginger 500mg Capsule 500 mg Oral General Nutrition Canada Inc. 2000-08-01 2007-08-01 Canada Ginger Capsules Capsule 1000 mg / cap Oral Vita Health Products Inc 1998-04-20 2002-08-01 Canada Ginger Root Cap Capsule 550 mg / cap Oral Attogram Corp 1994-12-31 1997-02-27 Canada Pain Relief Honzo Seika Chinese Herbal Aroma Oil Oil 28 mg/100mL Topical Phytopia Co., Ltd. 2016-04-01 Not applicable US Pain Relief Honzo Seika Chinese Herbal Aroma Oil Oil 28 mg/100mL Topical Nic Co., Ltd. 2016-04-01 Not applicable US Throat Calm Patch Patch 14 g/1001 Topical Guangzhou Hanhai Trading Co., Ltd 2023-09-19 Not applicable US Zinaxin Ev. Ext 77 Ginger Extract Capsule 3000 mg Oral Jamieson Laboratories Ltd 2002-10-01 2006-07-25 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image C Ottways Lax Tab Ginger (9 mg / tab) + Aloe vera leaf (132 mg / tab) + Capsicum (19 mg / tab) + Frangula purshiana bark (28 mg / tab) + Glycyrrhiza glabra (28 mg / tab) + Senna leaf (28 mg / tab) Tablet Oral C Ottway Herbalist 1950-12-31 1997-06-13 Canada Chungwidan-F Ginger (300 mg/30mL) + Cinnamon (500 mg/30mL) Liquid Oral Han Kook Shin Yak Pharmaceutical Co., Ltd. 2019-12-18 Not applicable US Herbal Anti-nausea Formula Ginger (500 mg / cap) + Peppermint (50 mg / cap) Capsule Oral Quest Vitamins A Div Of Purity Life Health Products 1999-02-08 2000-07-20 Canada Herbal Digestive Capsules Ginger (250 mg / cap) + Capsicum (50 mg / cap) Capsule Oral Jamieson Laboratories Ltd 1994-12-31 2001-09-14 Canada Kaydia Patch Ginger (0.5 g/100g) + Arnica montana flower (0.5 g/100g) + Curcumin (1 g/100g) + Magnesium chloride hexahydrate (2 g/100g) + Piperine (0.2 g/100g) + Pyridoxine (1 g/100g) + Thiamine chloride (1 g/100g) Patch Topical Strong Current Enterprises Limited 2020-05-01 Not applicable US Little Remedies Infant Essentials Ginger (5 mg/5mL) + Dimethicone (20 mg/0.3mL) + Fennel (4 mg/5mL) Kit; Liquid Oral Medtech Products Inc. 2019-02-15 Not applicable US Little Remedies New Baby Essentials Ginger (5 mg/5mL) + Acetaminophen (160 mg/5mL) + Dimethicone (20 mg/0.3mL) + Fennel (4 mg/5mL) + Zinc oxide (16 g/113g) Cream; Kit; Liquid Oral; Topical Medtech Products Inc. 2017-02-15 Not applicable US MIST CARMINATIVE Ginger (0.025 mL/5mL) + Camphor (10 mg/5mL) + Capsicum (0.02 ml/5mL) + Cardamom (0.045 mL/5mL) Solution บริษัท สหแพทย์เภสัช จำกัด 1987-09-30 Not applicable Thailand 
Naus-over Ginger (290 mg) + Peppermint (260 mg) + Peppermint oil (0.005 mg) Capsule Oral Health 2000 Inc. Not applicable Not applicable Canada SoCheongRyong Tang Extract Ginger (1 g/3g) + Chlorpheniramine maleate (0.00087 g/3g) + Dextromethorphan hydrobromide monohydrate (0.00515 g/3g) Granule Oral I World Pharmaceutical Co., Ltd. 2020-09-16 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image B-Nexa Ginger (100 mg/1) + Calcium (124.23 mg/1) + Folic acid (1.22 mg/1) + Pyridoxine (42 mg/1) Tablet Oral Upsher Smith Laboratories 2012-08-15 2015-04-30 US B-Nexa Ginger (100 mg/1) + Calcium (124.1 mg/1) + Folic acid (1.2 mg/1) + Pyridoxine (40 mg/1) Tablet Oral Upsher Smith Laboratories 2011-12-08 2014-02-28 US Chungwidan-F Ginger (300 mg/30mL) + Cinnamon (500 mg/30mL) Liquid Oral Han Kook Shin Yak Pharmaceutical Co., Ltd. 2019-12-18 Not applicable US Focalgin B Ginger (100 mg/1) + Calcium (124.23 mg/1) + Folic acid (1.22 mg/1) + Pyridoxine hydrochloride (42 mg/1) Tablet, film coated Oral Method Pharmaceuticals 2013-11-01 2015-06-30 US Kaydia Patch Ginger (0.5 g/100g) + Arnica montana flower (0.5 g/100g) + Curcumin (1 g/100g) + Magnesium chloride hexahydrate (2 g/100g) + Piperine (0.2 g/100g) + Pyridoxine (1 g/100g) + Thiamine chloride (1 g/100g) Patch Topical Strong Current Enterprises Limited 2020-05-01 Not applicable US Little Remedies Infant Essentials Ginger (5 mg/5mL) + Dimethicone (20 mg/0.3mL) + Fennel (4 mg/5mL) Kit; Liquid Oral Medtech Products Inc. 2019-02-15 Not applicable US Little Remedies New Baby Essentials Ginger (5 mg/5mL) + Acetaminophen (160 mg/5mL) + Dimethicone (20 mg/0.3mL) + Fennel (4 mg/5mL) + Zinc oxide (16 g/113g) Cream; Kit; Liquid Oral; Topical Medtech Products Inc. 2017-02-15 Not applicable US Pain Relief Honzo Seika Chinese Herbal Aroma Oil Ginger (28 mg/100mL) Oil Topical Phytopia Co., Ltd. 2016-04-01 Not applicable US Pain Relief Honzo Seika Chinese Herbal Aroma Oil Ginger (28 mg/100mL) Oil Topical Nic Co., Ltd. 2016-04-01 Not applicable US SoCheongRyong Tang Extract Ginger (1 g/3g) + Chlorpheniramine maleate (0.00087 g/3g) + Dextromethorphan hydrobromide monohydrate (0.00515 g/3g) Granule Oral I World Pharmaceutical Co., Ltd. 2020-09-16 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- C5529G5JPQ
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Vertigo 1 3 Completed Treatment Allergic Rhinitis (AR) 1 2, 3 Completed Prevention Nausea / Vomiting 1 2, 3 Unknown Status Treatment Osteoarthritis (OA) 1 1 Completed Treatment Acne Vulgaris 1 0 Completed Prevention The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Patch Transdermal Liquid Oral Tablet, film coated Oral Capsule Oral 710 mg / cap Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Capsule Oral 500 mg Capsule Oral 1000 mg / cap Capsule Oral 550 mg / cap Patch Topical Kit; liquid Oral Cream; kit; liquid Oral; Topical Solution Oil Topical 28 mg/100mL Capsule Oral 250 mg / cap Capsule Oral 1 g / cap Granule Oral Powder, for solution Oral Patch Topical 14 g/1001 Lotion Topical Capsule Oral Capsule Oral 3000 mg Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at September 25, 2023 18:32